| Nov 5 |
Apellis drops as disappointing Syfovre sales drive Q3 miss
|
| Nov 5 |
High Growth Tech Stocks to Watch in November 2024
|
| Nov 5 |
Apellis Pharmaceuticals, Inc. (APLS) Reports Q3 Loss, Lags Revenue Estimates
|
| Nov 5 |
Apellis Pharmaceuticals GAAP EPS of -$0.46 misses by $0.15, revenue of $196.83M misses by $2.99M
|
| Nov 5 |
Apellis Pharmaceuticals Reports Third Quarter 2024 Financial Results
|
| Nov 4 |
Apellis Pharmaceuticals Q3 2024 Earnings Preview
|
| Oct 30 |
Acadia Pharmaceuticals (ACAD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
| Oct 29 |
Will Apellis Pharmaceuticals, Inc. (APLS) Report Negative Earnings Next Week? What You Should Know
|
| Oct 29 |
1 Nasdaq Stock Down 62% This Year That Could Double Your Money, According to a Wall Street Analyst
|
| Oct 28 |
Apellis, Sobi announced results from Phase 3 VALIANT study
|
